Kahal, Hassan, Bristol

• British Journal of Diabetes Vol. 21 No. 1 (2021): June 2021 - Commentary
  Liraglutide (Saxenda®) for the treatment of obesity: a commentary on NICE Technology Appraisal 664
  Abstract  PDF  HTML